Branigan, G.P.; Casado-Medrano, V.; O’Neill, A.B.; Ricarte-Filho, J.C.; Massoll, N.; Salwen, M.; Spangler, Z.; Scheerer, M.; Williamson, E.K.; Bauer, A.J.;
et al. Development of Novel Murine BRAFV600E-Driven Papillary Thyroid Cancer Cell Lines for Modeling of Disease Progression and Preclinical Evaluation of Therapeutics. Cancers 2023, 15, 879.
https://doi.org/10.3390/cancers15030879
AMA Style
Branigan GP, Casado-Medrano V, O’Neill AB, Ricarte-Filho JC, Massoll N, Salwen M, Spangler Z, Scheerer M, Williamson EK, Bauer AJ,
et al. Development of Novel Murine BRAFV600E-Driven Papillary Thyroid Cancer Cell Lines for Modeling of Disease Progression and Preclinical Evaluation of Therapeutics. Cancers. 2023; 15(3):879.
https://doi.org/10.3390/cancers15030879
Chicago/Turabian Style
Branigan, Grace Purvis, Victoria Casado-Medrano, Alison B. O’Neill, Julio C. Ricarte-Filho, Nicole Massoll, Madeleine Salwen, Zachary Spangler, Michele Scheerer, Edward K. Williamson, Andrew J. Bauer,
and et al. 2023. "Development of Novel Murine BRAFV600E-Driven Papillary Thyroid Cancer Cell Lines for Modeling of Disease Progression and Preclinical Evaluation of Therapeutics" Cancers 15, no. 3: 879.
https://doi.org/10.3390/cancers15030879
APA Style
Branigan, G. P., Casado-Medrano, V., O’Neill, A. B., Ricarte-Filho, J. C., Massoll, N., Salwen, M., Spangler, Z., Scheerer, M., Williamson, E. K., Bauer, A. J., & Franco, A. T.
(2023). Development of Novel Murine BRAFV600E-Driven Papillary Thyroid Cancer Cell Lines for Modeling of Disease Progression and Preclinical Evaluation of Therapeutics. Cancers, 15(3), 879.
https://doi.org/10.3390/cancers15030879